Wellgistics Health, Inc. Common Stock Net Assets
Wellgistics Health, Inc. Common Stock net assets. Based on the latest financial reports, Wellgistics Health, Inc. Common Stock (WGRX) has net assets worth $-15.06 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($30.13 Million) and total liabilities ($45.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Wellgistics Health, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-15.06 Million |
| % of Total Assets | -50.0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Net Assets of Wellgistics Health, Inc. Common Stock (2022–2025)
Net assets of Wellgistics Health, Inc. Common Stock from 2022 to 2025. This chart illustrates how Wellgistics Health, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. See WGRX net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Wellgistics Health, Inc. Common Stock (2022–2025)
The table below shows the annual net assets of Wellgistics Health, Inc. Common Stock from 2022 to 2025. For live market cap and overall valuation, see WGRX company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-12.45 Million | -284.84% |
| 2024-12-31 | $6.73 Million | +332.19% |
| 2023-12-31 | $-2.90 Million | -55146.36% |
| 2022-12-31 | $-5.25K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wellgistics Health, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11102644000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Wellgistics Health, Inc. Common Stock Net Assets Breakdown (December 2025)
Wellgistics Health, Inc. Common Stock net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.13K | % |
| Other Components | $98.57 Million | % |
| Total Equity | $-12.45 Million | 100.00% |
Wellgistics Health, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Wellgistics Health, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Horizon Gold Ltd
AU:HRN
|
$157.45 Million |
|
Helloworld Travel Ltd
AU:HLO
|
$157.51 Million |
|
1Stdibs.Com Inc
NASDAQ:DIBS
|
$157.59 Million |
|
Shanghai Longyun Advg & Media
SHG:603729
|
$157.62 Million |
|
Tachan Securities Co Ltd
TWO:6020
|
$157.42 Million |
|
Mayfair Gold Corp
V:MFG
|
$157.36 Million |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
$157.35 Million |
|
Saniona AB
ST:SANION
|
$157.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellgistics Health, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,734,446 to -12,447,801, a change of -19,182,247 (-284.8%).
- Net loss of 101,274,530 reduced equity.
- Share repurchases of 2,838,787 reduced equity.
- New share issuances of 11,372,840 increased equity.
- Other factors increased equity by 73,558,230.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-101.27 Million | -813.59% |
| Share Repurchases | $2.84 Million | -22.81% |
| Share Issuances | $11.37 Million | +91.36% |
| Other Changes | $73.56 Million | +590.93% |
| Total Change | $- | -284.84% |
Book Value vs Market Value Analysis
This analysis compares Wellgistics Health, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $-0.01 | $3.03 | x |
| 2023-12-31 | $-3.24 | $3.03 | x |
| 2024-12-31 | $6.48 | $3.03 | x |
| 2025-12-31 | $-8.77 | $3.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellgistics Health, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -433.95%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-25.45%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 0.00% | -8.37% | 0.00x | 0.00x | $-2.74 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.61 Million |
| 2024 | -101.81% | -37.82% | 0.32x | 8.51x | $-7.53 Million |
| 2025 | 0.00% | -433.95% | 0.77x | 0.00x | $-100.03 Million |
Industry Comparison
This section compares Wellgistics Health, Inc. Common Stock's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,527,050,798
- Average return on equity (ROE) among peers: -14.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellgistics Health, Inc. Common Stock (WGRX) | $-15.06 Million | 0.00% | N/A | $157.43 Million |
| Accendra Health Inc (ACH) | $1.03 Billion | 10.82% | 1.27x | $21.62 Million |
| Akso Health Group ADR (AHG) | $48.10 Million | -148.02% | 0.67x | $807.33 Million |
| Cardinal Health Inc (CAH) | $6.33 Billion | 21.53% | 5.47x | $43.01 Billion |
| Cencora Inc. (COR) | $4.34 Billion | 10.79% | 1.69x | $61.32 Billion |
| Cosmos Health Inc. (COSM) | $-1.75 Million | 0.00% | 0.00x | $15.91 Million |
| EDAP TMS SA (EDAP) | $33.82 Million | 0.54% | 0.51x | $154.80 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $143.05 Million |
| EDAP TMS S.A. (FOCL) | $56.92 Million | 1.45% | 0.54x | $154.24 Million |
| Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) | $9.58 Million | -11.85% | 0.34x | $5.95 Million |
| Henry Schein Inc (HSIC) | $3.43 Billion | 13.97% | 0.90x | $7.86 Billion |
About Wellgistics Health, Inc. Common Stock
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, … Read more